Logo image of BRED.CA

PUREBREAD BRANDS INC (BRED.CA) Stock Fundamental Analysis

TSX-V:BRED - TSX Venture Exchange - CA74624T2065 - Common Stock - Currency: CAD

0.15  +0.02 (+15.38%)

Fundamental Rating

1

BRED gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of BRED have multiple concerns. BRED is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BRED has reported negative net income.
BRED had a positive operating cash flow in the past year.
BRED.CA Yearly Net Income VS EBIT VS OCF VS FCFBRED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -26.26%
ROE N/A
ROIC N/A
ROA(3y)-72.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRED.CA Yearly ROA, ROE, ROICBRED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200K -400K -600K -800K

1.3 Margins

In the last couple of years the Gross Margin of BRED has declined.
BRED does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.64%
GM growth 5YN/A
BRED.CA Yearly Profit, Operating, Gross MarginsBRED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300 -400

0

2. Health

2.1 Basic Checks

BRED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BRED has more shares outstanding
Compared to 1 year ago, BRED has an improved debt to assets ratio.
BRED.CA Yearly Shares OutstandingBRED.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
BRED.CA Yearly Total Debt VS Total AssetsBRED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -1.97, we must say that BRED is in the distress zone and has some risk of bankruptcy.
BRED has a debt to FCF ratio of 10.66. This is a negative value and a sign of low solvency as BRED would need 10.66 years to pay back of all of its debts.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.66
Altman-Z -1.97
ROIC/WACCN/A
WACC4.46%
BRED.CA Yearly LT Debt VS Equity VS FCFBRED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

BRED has a Current Ratio of 0.06. This is a bad value and indicates that BRED is not financially healthy enough and could expect problems in meeting its short term obligations.
BRED has a Quick Ratio of 0.06. This is a bad value and indicates that BRED is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
BRED.CA Yearly Current Assets VS Current LiabilitesBRED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

3

3. Growth

3.1 Past

BRED shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.60%.
Looking at the last year, BRED shows a very strong growth in Revenue. The Revenue has grown by 316.20%.
Measured over the past years, BRED shows a very strong growth in Revenue. The Revenue has been growing by 115.70% on average per year.
EPS 1Y (TTM)-1.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5%
Revenue 1Y (TTM)316.2%
Revenue growth 3Y115.7%
Revenue growth 5YN/A
Sales Q2Q%-9.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRED.CA Yearly Revenue VS EstimatesBRED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRED. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRED.CA Price Earnings VS Forward Price EarningsBRED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1.47
EV/EBITDA N/A
BRED.CA Per share dataBRED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRED!.
Industry RankSector Rank
Dividend Yield N/A

PUREBREAD BRANDS INC

TSX-V:BRED (6/19/2025, 7:00:00 PM)

0.15

+0.02 (+15.38%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.71%
Ins Owner ChangeN/A
Market Cap3.48M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF 1.47
P/OCF 11.81
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY68.01%
OCF(TTM)0.01
OCFY8.47%
SpS0.71
BVpS-0.33
TBVpS-0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.9%
FCFM 14.38%
ROA(3y)-72.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.64%
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.66
Debt/EBITDA N/A
Cap/Depr 95.84%
Cap/Sales 12.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -1.97
F-Score4
WACC4.46%
ROIC/WACCN/A
Cap/Depr(3y)132.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)52.16%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)316.2%
Revenue growth 3Y115.7%
Revenue growth 5YN/A
Sales Q2Q%-9.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.24%
OCF growth 3YN/A
OCF growth 5YN/A